How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/investigational-varicella-vaccine-lot-1.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Investigational varicella vaccine_Lot 1 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigational varicella vaccine_Lot 1 (Investigational varicella vaccine_Lot 1) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine or inactivated vaccine. Area: Immunology / Infectious Disease.

phase 3 Live attenuated vaccine or inactivated vaccine Varicella-zoster virus (VZV) antigens Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Investigational varicella vaccine_Lot 1 (Investigational varicella vaccine_Lot 1) — GlaxoSmithKline. This investigational vaccine stimulates the immune system to recognize and prevent varicella-zoster virus infection by inducing protective antibodies and cell-mediated immunity.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Investigational varicella vaccine_Lot 1 TARGET	Investigational varicella vaccine_Lot 1	GlaxoSmithKline	phase 3	Live attenuated vaccine or inactivated vaccine	Varicella-zoster virus (VZV) antigens
Chickenpox Vaccines	Chickenpox Vaccines	Southeast University, China	phase 3	Live attenuated vaccine or inactivated vaccine	Varicella-zoster virus (VZV) glycoproteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine or inactivated vaccine class)

GlaxoSmithKline · 1 drug in this class
Southeast University, China · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Investigational varicella vaccine_Lot 1 — Competitive Intelligence Brief. https://druglandscape.com/ci/investigational-varicella-vaccine-lot-1. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab